title: Ensuring safe and effective drugs: who can do what it takes?
authors.affiliation: Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy.
authors.forename: Tom
authors.initials: T
authors.lastname: Jefferson
authors.forename: Peter
authors.initials: P
authors.lastname: Doshi
authors.forename: Matthew
authors.initials: M
authors.lastname: Thompson
authors.forename: Carl
authors.initials: C
authors.lastname: Heneghan
mesh_terms: D002986:Clinical Trials as Topic; D003625:Data Collection; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir / Q000627:therapeutic use*; D012196:Review Literature as Topic; D015983:Selection Bias
chemical_list: D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase